LOXL2 and systemic sclerosis: However, in the fibrotic condition as severe as SSc, where both LOX and LOXL2 are upregulated, pan-lysyl oxidase inhibition using PXS-5505 may be more efficacious by inhibiting all lysyl oxidase isoforms.